In the latest episode of The Line Podcast, recorded on October 2nd, 2026, Matt Gurney and Jen Gerson begin with the announcement of the new Pacific Link pipeline, unveiled by Prime Minister Mark Carney alongside Alberta Premier Danielle Smith. Your hosts are struck by just how much Carney increasingly sounds like a spiritual — and even political — successor to Stephen Harper or Jason Kenney, rather than Justin Trudeau. That also fits with some of what The Line has been hearing about how these various gentlemen view each other.
This episode is brought to you by Fractional Execs Canada. Need help with a serious business problem? As Canadian businesses grow they often require expert help to solve key business challenges. Fractional Execs Canada have assembled a team of experienced strategists, implementors, sales and marketing operators that can help transform your business into a growth engine. They match you with the right person, or team to move your business forward at a pace your business can manage.
Talk to Fractional Execs Canada and discover a better, more collaborative way to take your business and your ‘busyness’ in a better direction. Canadian expertise to support the growth of Canadian businesses. Build your business with those that know how.
Find them Fractional-Execs.ca.
The pipeline also gives Canadians something unusually useful: a clear benchmark for judging the Carney government. The “Carney method” has committed to getting the project shovel-ready in just one year. That’s a much easier promise to evaluate than grand plans whose results might not become apparent for a decade. So we’ll be watching.
Next, your hosts turn to another speech in Alberta. Conservative leader Pierre Poilievre spoke in Edmonton this week about why Alberta should remain in Canada. Jen was impressed by the speech — but also thinks it’s too little, too late. Matt argues that the Conservatives increasingly talk about Alberta staying in Canada the way the Liberals talk about antisemitism: they don’t seem particularly invested in the issue, but they know they need to tick the appropriate boxes so nobody can accuse them of saying nothing.
This episode is also brought to you by Cardus. For years, Ayaan Hirsi Ali was one of the most famous atheists in the world. Then she converted to Christianity. Now she argues that faith is the key to renewing Western civilization. Hear her make the case live in Calgary, October 8th, at the 2026 Ian Shugart Lecture, hosted by the think tank Cardus. Get your tickets at Cardus.ca/ayaan.
Finally, Matt and Jen venture outside their usual Canadian focus to discuss the case of Christa Pike, the Tennessee woman scheduled to be executed this week after three decades on death row for a horrific murder. The state botched the execution despite warnings that exactly that could happen. Your hosts discuss their own views on capital punishment and wrestle with a larger question: is there a position on the death penalty that could satisfy the public while still respecting the concerns that make so many Canadian elites recoil from it?
This episode is also brought to you by BioCanRx. We’ve been partnering with federally-funded Canadian not-for-profit BioCanRx to learn how made-in-Canada immunotherapies offer new ways to beat cancer. This September we’re focusing on the “made-in-Canada” part.
Unlike other G7 nations, Canada lacks an anchor company and patient capital with pockets deep enough to pay for the lengthy process of bringing drugs to the Canadian market. Not for profits like BioCanRx are stepping in, but if the government decides to inject funding into the pipeline, how can we be sure money is going to projects with a real chance to succeed? Performance monitoring is essential, because if you’re going to fail it’s better to do it quickly. BioCanRx checks on all its funded projects every six months. Advised by a group of international experts, project milestones are tracked and, if necessary, funds can be cut.
Government departments won’t have the technical expertise to scrutinize researchers that closely, but by leveraging partners with the necessary expertise they could make sure taxpayer dollars are being invested wisely. Thanks to BioCanRx for continuing to help us tell this story. Visit BioCanRx.com to learn more.
All that and more in the latest episode of The Line Podcast. Like and subscribe!
YouTube:
Video goes live at 6 p.m Eastern/4 Mountain.
Spotify:
Apple:
Please sign up at those options not just for this episode, or future episodes of The Line Podcast, but so that you can also receive our other podcast series, On the Line, which releases new episodes every Tuesday morning. In case you missed it, here is last Tuesday’s episode, where Matt Gurney caught up with Stephanie Levitz from The Globe and Mail for all the latest and greatest news out of Ottawa.
That’s all for now! Talk to you guys soon.
The Line is entirely reader and advertiser funded. No federal subsidies, no bailouts. If you value our work, please consider supporting us by subscribing or making a donation. Donations are not subscriptions and do not unlock paywalled content, but they help keep The Line independent
To contact The Line with a general inquiry or comment, please email info@readtheline.ca. For other ways to connect with us or to follow us on social media, please see our LinkTree.
